131 related articles for article (PubMed ID: 7707487)
1. Pharmacokinetics of parenteral and oral sustained-release morphine sulphate in dogs.
Dohoo S; Tasker RA; Donald A
J Vet Pharmacol Ther; 1994 Dec; 17(6):426-33. PubMed ID: 7707487
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of oral morphine sulfate in dogs: a comparison of sustained release and conventional formulations.
Dohoo SE; Tasker RA
Can J Vet Res; 1997 Oct; 61(4):251-5. PubMed ID: 9342447
[TBL] [Abstract][Full Text] [Related]
3. Steady-state pharmacokinetics of oral sustained-release morphine sulphate in dogs.
Dohoo S
J Vet Pharmacol Ther; 1997 Apr; 20(2):129-33. PubMed ID: 9131539
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of morphine and plasma concentrations of morphine-6-glucuronide following morphine administration to dogs.
KuKanich B; Lascelles BD; Papich MG
J Vet Pharmacol Ther; 2005 Aug; 28(4):371-6. PubMed ID: 16050817
[TBL] [Abstract][Full Text] [Related]
5. Sustained relief of chronic pain. Pharmacokinetics of sustained release morphine.
Gourlay GK
Clin Pharmacokinet; 1998 Sep; 35(3):173-90. PubMed ID: 9784932
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of an injectable sustained-release formulation of morphine for use in dogs.
Tasker RA; Ross SJ; Dohoo SE; Elson CM
J Vet Pharmacol Ther; 1997 Oct; 20(5):362-7. PubMed ID: 9350256
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics, pharmacodynamics, and analgesic effects of morphine after rectal, intramuscular, and intravenous administration in dogs.
Barnhart MD; Hubbell JA; Muir WW; Sams RA; Bednarski RM
Am J Vet Res; 2000 Jan; 61(1):24-8. PubMed ID: 10630773
[TBL] [Abstract][Full Text] [Related]
8. Morphine, pethidine and buprenorphine disposition in the cat.
Taylor PM; Robertson SA; Dixon MJ; Ruprah M; Sear JW; Lascelles BD; Waters C; Bloomfield M
J Vet Pharmacol Ther; 2001 Dec; 24(6):391-8. PubMed ID: 11903869
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of an immediate and extended release oral morphine formulation utilizing the spheroidal oral drug absorption system in dogs.
Aragon CL; Read MR; Gaynor JS; Barnhart MD; Wilson D; Papich MG
J Vet Pharmacol Ther; 2009 Apr; 32(2):129-36. PubMed ID: 19290942
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of clindamycin HCl administered intravenously, intramuscularly and subcutaneously to dogs.
Lavy E; Ziv G; Shem-Tov M; Glickman A; Dey A
J Vet Pharmacol Ther; 1999 Aug; 22(4):261-5. PubMed ID: 10499238
[TBL] [Abstract][Full Text] [Related]
11. Clinical efficacy, safety and pharmacokinetics of a newly developed controlled release morphine sulphate suppository in patients with cancer pain.
Moolenaar F; Meijler WJ; Frijlink HW; Visser J; Proost JH
Eur J Clin Pharmacol; 2000 Jun; 56(3):219-23. PubMed ID: 10952476
[TBL] [Abstract][Full Text] [Related]
12. High-dose morphine and methadone in cancer patients. Clinical pharmacokinetic considerations of oral treatment.
Säwe J
Clin Pharmacokinet; 1986; 11(2):87-106. PubMed ID: 3514045
[TBL] [Abstract][Full Text] [Related]
13. Comparative morphine pharmacokinetics following sublingual, intramuscular, and oral administration in patients with cancer.
Davis T; Miser AW; Loprinzi CL; Kaur JS; Burnham NL; Dose AM; Ames MM
Hosp J; 1993; 9(1):85-90. PubMed ID: 8406404
[TBL] [Abstract][Full Text] [Related]
14. Plasma pharmacokinetics and bioavailability of 1-(2-chloroethyl)-3-sarcosinamide-1-nitrosourea after intravenous and oral administration to mice and dogs.
Supko JG; Garcia-Carbonero R; Puchalski TA; Malspeis L
Cancer Chemother Pharmacol; 2001 Sep; 48(3):202-8. PubMed ID: 11592341
[TBL] [Abstract][Full Text] [Related]
15. Does intraosseous equal intravenous? A pharmacokinetic study.
Von Hoff DD; Kuhn JG; Burris HA; Miller LJ
Am J Emerg Med; 2008 Jan; 26(1):31-8. PubMed ID: 18082778
[TBL] [Abstract][Full Text] [Related]
16. Morphine pharmacokinetics after pulmonary administration from a novel aerosol delivery system.
Ward ME; Woodhouse A; Mather LE; Farr SJ; Okikawa JK; Lloyd P; Schuster JA; Rubsamen RM
Clin Pharmacol Ther; 1997 Dec; 62(6):596-609. PubMed ID: 9433388
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of ethylene glycol. III. Plasma disposition and metabolic fate after single increasing intravenous, peroral, or percutaneous doses in the male Sprague-Dawley rat.
Frantz SW; Beskitt JL; Tallant MJ; Zourelias LA; Ballantyne B
Xenobiotica; 1996 May; 26(5):515-39. PubMed ID: 8736063
[TBL] [Abstract][Full Text] [Related]
18. Steady-state pharmacokinetic evaluation of a novel, controlled-release morphine suppository and subcutaneous morphine in cancer pain.
Bruera E; Fainsinger R; Spachynski K; Babul N; Harsanyi Z; Darke AC
J Clin Pharmacol; 1995 Jul; 35(7):666-72. PubMed ID: 7560246
[TBL] [Abstract][Full Text] [Related]
19. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
Chen C; Bujanover S; Kareht S; Rapoport AM
Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of intramuscularly administered morphine in horses.
Devine EP; KuKanich B; Beard WL
J Am Vet Med Assoc; 2013 Jul; 243(1):105-12. PubMed ID: 23786198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
